SCHEMBL6794762

SCHEMBL6794762

Nc1cc2c(cc1OC(=O)C(F)(F)F)CCc1c-2nn2c1C(=O)NCCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6791559 0.86 MAPKAPK2 (0.32)
SCHEMBL6798081 0.85 MAPKAPK2 (0.34)
Trifluoroacetic Acid SCHEMBL6794758 0.84 KDM1A (0.34)
SCHEMBL4260060 0.80 ALPL (0.34)
Trifluoroacetic Acid SCHEMBL6791557 0.75 MAPKAPK2 (0.33)
SCHEMBL4270927 0.74 MAPKAPK2 (0.41)
SCHEMBL6794644 0.72 MAOA (0.38)
SCHEMBL4255914 0.70
SCHEMBL6792527 0.70 SIGMAR1 (0.33)
Trifluoroacetic Acid SCHEMBL6795002 0.69 SIGMAR1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040127492-A1 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 PHARMACIA CORPORATION 2004-07-01 US claimed
US-20040127492-A1 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 PHARMACIA CORPORATION 2004-07-01 US disclosed